Low PE penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!
Low PE penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!

Low PE penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!

The stock has a PE of 18.60x whereas the industry PE is 30x.

Kiran Shroff Article rating: 3.8

Earum Pharmaceuticals has a market cap of Rs 36.82 crore. The company reported positive numbers in its both quarterly results and annual results. The stock has a PE of 18.60x whereas the industry PE is 30x.

Heavy buying witnessed in this penny stock under Rs 5; Board likely to announce bonus shares and stock split!
Heavy buying witnessed in this penny stock under Rs 5; Board likely to announce bonus shares and stock split!

Heavy buying witnessed in this penny stock under Rs 5; Board likely to announce bonus shares and stock split!

The stock has a 52-week high of Rs 3.68 and a 52-week low of Rs 1.52.

Kiran Shroff Article rating: 3.8

Earum Pharmaceuticals Limited produces and distributes pharmaceutical products. The company offers tablets, capsules, ointments, creams, gels, powders, and syrup. Earum Pharmaceuticals markets its products globally.

Penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!
Penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!

Penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!

The shares of the company saw a spurt in volume by more than 2.20 times on BSE.

Kiran Shroff Article rating: 3.7

Earum Pharmaceuticals Limited produces and distributes pharmaceutical products. The Company offers tablets, capsules, ointments, creams, gels, powders, and syrup. Earum Pharmaceuticals markets its products globally.

DSIJ MINDSHARE

Mkt Commentary4-Nov, 2024

Multibaggers4-Nov, 2024

Penny Stocks4-Nov, 2024

Mindshare4-Nov, 2024

Mindshare4-Nov, 2024

Knowledge

MF28-Oct, 2024

Personal Finance28-Oct, 2024

Technical23-Oct, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR